Zhubei, Taiwan

Chih-Kai Hsu

This inventor holds 3 USPTO granted patents and 7 published patent applications and 1 EPO patent. Top assignee: Taiwan Mitochondrion Applied Technology. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chih-Kai Hsu. Retrieved from https://idiyas.com/inventor/chih-kai-hsu-2wu6elx3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.7

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Chih-Kai Hsu: Innovator in Mitochondrial Applications

Introduction

Chih-Kai Hsu is an innovative inventor based in Zhubei, Taiwan. He is currently associated with Taiwan Mitochondrion Applied Technology Co., Ltd. Despite having no granted patents to his name, Hsu is actively involved in developing groundbreaking compositions aimed at addressing significant health issues.

Latest Patent Applications

Hsu's latest patent applications include:

1. **Composition for Oral Damage Mitigation, Use Thereof, and Manufacturing Method Thereof** - This application discloses a composition that includes mitochondria and a biocompatible carrier. The composition is designed to mitigate, repair, ameliorate, or treat oral damage, particularly periodontal diseases or oral cancers, while ensuring safety and effectiveness.

2. **Composition for Hearing Loss Mitigation and Use Thereof** - This application presents a composition that also includes mitochondria and a biocompatible carrier. It aims to mitigate, repair, ameliorate, or treat hearing loss, emphasizing both safety and effectiveness.

Conclusion

Chih-Kai Hsu is making strides in the field of mitochondrial applications, focusing on innovative solutions for oral and auditory health challenges. His work holds promise for future advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…